Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.

MLA

Cheng-Mei Yang, et al. “Aberrant DNA Hypermethylation-Silenced SOX21-AS1 Gene Expression and Its Clinical Importance in Oral Cancer.” Clinical Epigenetics, vol. 8, Nov. 2016, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13148-016-0291-5.

APA

Cheng-Mei Yang, Tsung-Han Wang, Hung-Chih Chen, Sung-Chou Li, Ming-Chien Lee, Huei-Han Liou, Pei-Feng Liu, Yu-Kai Tseng, Yow-Ling Shiue, Luo-Ping Ger, & Kuo-Wang Tsai. (2016). Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer. Clinical Epigenetics, 8, 1–13. https://doi.org/10.1186/s13148-016-0291-5

Chicago

Cheng-Mei Yang, Tsung-Han Wang, Hung-Chih Chen, Sung-Chou Li, Ming-Chien Lee, Huei-Han Liou, Pei-Feng Liu, et al. 2016. “Aberrant DNA Hypermethylation-Silenced SOX21-AS1 Gene Expression and Its Clinical Importance in Oral Cancer.” Clinical Epigenetics 8 (November): 1–13. doi:10.1186/s13148-016-0291-5.